Difference in dominant negative activities between mutant thyroid hormone receptors α1 and β1 with an identical truncation in the extreme carboxyl-terminal tau4 domain

Molecular and Cellular Endocrinology

Volumn 138, Issue 1-2, 1998, Pages 95-104

  Nishiyama, Kozo ^a   Andoh, Shinichiro ^a   Kitahara, Akira ^a   Natsume, Hiroko ^a   Mikami, Tomoko ^a   Genma, Rieko ^a   Nakamura, Hirotoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dominant negative effect; Resistance to thyroid hormone; Thyroid hormone receptor

Indexed keywords

MUTANT PROTEIN; TAU PROTEIN; THYROID HORMONE RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; EXPRESSION VECTOR; GENE STRUCTURE; HUMAN; PRIORITY JOURNAL; RECEPTOR GENE; THYROID GLAND; TRANSACTIVATION;

ANIMALS; CELL LINE; CHICKENS; CHILD; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DIMERIZATION; FEMALE; HUMANS; MURAMIDASE; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RETINOID X RECEPTORS; SEQUENCE DELETION; THYROID HORMONE RESISTANCE SYNDROME; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRIIODOTHYRONINE;

EID: 0032536719     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00014-8     Document Type: Article

References (36)

1. Baniahmad, A., Leng, X., Burris, T.P., Tsai, S.Y., Tsai, M.J., O'Malley, B.W., 1995. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15, 76-86.
2. Barettino, D., Vivanco, R.M., Stunnenberg, H.G., 1994. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13, 3039-3049.
3. Beck, P.P., Chatterjee, V.K., Chin, W.W., DeGroot, L.J., Jameson, J.L., Nakamura, H., Refetoff, S., Usala, S.J., Weintraub, B.D., 1994. Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom. J. Clin. Endcrinol. Metab. 78, 990-993.
4. Bradley, D.J., Young, W.3., Weinberger, C., 1989. Differential expression of alpha and beta thyroid hormone receptor genes in rat brain and pituitary. Proc. Natl. Acad. Sci. USA 86, 7250-7254.
5. Chen, J.D., Evans, R.M., 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454-457.
6. Danielian, P.S., White, R., Lees, J.A., Parker, M.G., 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11, 1025-1033.
7. Darling, D.S., Carter, R.L., Yen, P.M., Welborn, J.M., Chin, W.W., Umeda, P.K., 1993. Different dimerization activities of alpha and beta thyroid hormone receptor isoforms. J. Biol. Chem. 268, 10221-10227.
8. De Wet, J.R., Wood, K.V., DeLuca, M., Helinski, D.R., Subramani, S., 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7, 725-737.
9. Durand, B., Saunders, M., Gaudon, C., Roy, B., Losson, R., Chambon, P., 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13, 5370-5382.
10. Forrest, D., Hallbook, F., Persson, H., Vennstrom, B., 1991. Distinct functions for thyroid hormone receptors alpha and beta in brain development indicated by differential expression of receptor genes. EMBO J. 10, 269-275.
11. Hallenbeck, P.L., Marks, M.S., Lippoldt, R. E., Ozato, K., Nikodem, V.M., 1992. Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXR beta) enhances DNA binding and TH-dependent transcriptional activation. Proc. Natl. Acad. Sci. USA 89, 5572-5576.
12. Herbomel, P., Bourachot, B., Yaniv, M., 1984. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39, 653-662.
13. Hodin, R.A., Lazar, M.A., Chin, W.W., 1990. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J. Clin. Invest. 85, 101-105.
14. Horlein, A.J., Naar, A.M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Soderstrom, M., Glass, C.K., Rosenfeld, M.G., 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor. Nature 377, 397-404.
15. Lazar, M.A, 1993. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 14, 184-193.
16. Leid, M., Kastner, P., Lyons, R., Nakshatri, H., Saunders, M., Zacharewski, T., Chen, J.Y., Staub, A., Garnier, J.M., Mader, S., Chambon, P., 1992. Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68, 377-395.
17. Mellstrom, B., Naranjo, J.R., Santos, A., Gonzalez, A.M., Bernal, J., 1991. Independent expression of the alpha and beta c-erbA genes in developing rat brain. Mol. Endocrinol. 5, 1339-1350.
18. Miyoshi, Y., Nakamura, H., Sasaki, S., Tagami, T., Misaki, T., Konishi, J., Nakeo, K., 1995. Two consecutive nucleotide substitutions in the T3 receptor β gene resulting in an 11-amino acid truncation in a patient with generalized resistance to thyroid hormone. Mol. Cell. Endocrinol. 114, 9-17.
19. Nakamura, H., Yokota, T., Imura, H., 1985. Different alterations of nuclear triiodothyronine receptor capacity in liver and kidney induced by starvation and triiodothyronine administration. Acta Endocrinol. 108, 206-210.
20. Nakamura, H., Tagami, T., Masuda, K., Mitani, T., Imura, H., 1989. Recognition of rat liver and kidney nuclear T3 receptors by an antibody against c-erb A peptide. Biochem. Biophys. Res. Commun. 160, 148-153.
21. Neumann, J.R., Morency, C.A., Russian, K.O., 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. Bio. Techniques 5, 444-447.
22. Onate, S.A., Tsai, S.Y., Tsai, M.J., O'Malley, B.W., 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357.
23. Piedrafita, F.J., Ortiz, M.A., Pfahl, M., 1995. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function. Mol. Endocrinol. 9, 1533-1548.
24. Refetoff, S., Weiss, R.E., Usala, S.J., 1993. The syndromes of resistance to thyroid hormone. Endocr. Rev. 14, 348-399.
25. Samuels, H.H., Stanley, F., Casanova, J., 1979. Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105, 80-85.
26. Saatcioglu, F., Bartunek, P., Deng, T., Zenke, M., Karin, M., 1993. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol. Cell. Biol. 13, 3675-3685.
27. Sasaki, S., Nakamura, H., Tagami, T., Miyoshi, Y., Nakao, K., 1995. Functional properties of a mutant T3 receptor β (R338W) identified in a subject with pituitary resistance to thyroid hormone. Mol. Cell. Endocrinol. 113, 109-117.
28. Strait, K.A., Schwartz, H.L., Perez, C.A., Oppenheimer, J.H., 1990. Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. J. Biol. Chem. 265, 10514-10521.
29. Tagami, T., Nakamura, H., Sasaki, S., Imura, H., 1990. Characterization of interaction between nuclear T3 receptors and antiserum against cellular-erb A peptide. Endocrinology 126, 1105-1111.
30. Tagami, T., Nakamura, H., Sasaki, S., Miyoshi, Y., Imura, H., 1993. Estimation of the protein content of thyroid hormone receptor alpha 1 and beta 1 in rat tissues by western blotting. Endocrinology 132, 275-279.
31. Umesono, K., Murakami, K.K., Thompson, C.C., Evans, R.M., 1991. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65, 1255-1266.
32. Vom Baur, E., Zechel, C., Heery, D., Heine, M.J., Garnier, J.M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P., Losson, R., 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15, 110-124.
33. Yen, P.M., Darling, D.S., Carter, R.L., Forgione, M., Umeda, P.K., Chin, W.W., 1992a. Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxiliary protein heterodimers. J. Biol. Chem. 267, 3565-3568.
34. Yen, P.M., Sugawara, A., Refetoff, S., Chin, W.W., 1992b. New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone. J. Clin. Invest. 90, 1825-1831.
35. Zavacki, A.M., Harney, J.W., Brent, G.A., Larsen, P.R., 1993. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol. Endocrinol. 7, 1319-1330.
36. Zhang, X.K., Hoffmann, B., Tran, P.B., Graugner, G., Pfahl, M., 1992. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355, 441-446.